Filing Details

Accession Number:
0000884905-13-000116
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-05 12:42:20
Reporting Period:
2013-11-04
Filing Date:
2013-11-05
Accepted Time:
2013-11-05 12:42:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884905 Praxair Inc PX Industrial Inorganic Chemicals (2810) 061249050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311774 T James Breedlove C/O Praxair, Inc.
39 Old Ridgebury Road
Danbury CT 06810-5113
Senior Vp, Gen. Counsel & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-04 2,000 $123.95 35,614 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,194 Indirect 401(k)
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $83.89 2009-02-26 2018-02-26 39,300 39,300 Direct
Common Stock Stock Option (right to buy) $60.92 2010-02-24 2019-02-24 44,120 44,120 Direct
Common Stock Stock Option (right to buy) $76.16 2011-02-23 2020-02-23 34,960 34,960 Direct
Common Stock Stock Option (right to buy) $97.84 2012-02-22 2021-02-22 37,930 37,930 Direct
Common Stock Stock Option (right to buy) $109.68 2013-02-28 2022-02-28 36,095 36,095 Direct
Common Stock Stock Option (right to buy) $110.58 2014-02-26 2023-02-26 29,755 29,755 Direct
Common Stock Deferred Stock $0.00 1,247 1,247 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-26 39,300 39,300 Direct
2019-02-24 44,120 44,120 Direct
2020-02-23 34,960 34,960 Direct
2021-02-22 37,930 37,930 Direct
2022-02-28 36,095 36,095 Direct
2023-02-26 29,755 29,755 Direct
1,247 1,247 Direct
Footnotes
  1. The $123.946 price reported is the sale price for all shares sold.
  2. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  3. This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
  4. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
  5. This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
  6. Conversion to Praxair Common Stock is on a 1-for-1 basis.
  7. Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.